GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Inventories, Raw Materials & Components

CSPC Pharmaceutical Group (HKSE:01093) Inventories, Raw Materials & Components : HK$0 Mil (As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Inventories, Raw Materials & Components?

CSPC Pharmaceutical Group's inventories, raw materials & components for the quarter that ended in Jun. 2024 was HK$0 Mil.

CSPC Pharmaceutical Group's quarterly raw materials declined from Dec. 2023 (HK$1,009 Mil) to Mar. 2024 (HK$0 Mil) but then stayed the same from Mar. 2024 (HK$0 Mil) to Jun. 2024 (HK$0 Mil).

CSPC Pharmaceutical Group's annual raw materials declined from Dec. 2021 (HK$937 Mil) to Dec. 2022 (HK$905 Mil) but then increased from Dec. 2022 (HK$905 Mil) to Dec. 2023 (HK$1,009 Mil).

CSPC Pharmaceutical Group Inventories, Raw Materials & Components Historical Data

The historical data trend for CSPC Pharmaceutical Group's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Inventories, Raw Materials & Components Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 510.48 622.59 937.29 905.43 1,009.16

CSPC Pharmaceutical Group Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,009.16 - - -

CSPC Pharmaceutical Group Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

CSPC Pharmaceutical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
HKSE:01666 HKSE:01643 LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578
Traded in Other Exchanges
CSPCY:USA CHJTF:USA CVGU:Germany CVG:Germany CVG:Germany
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
Website
https://www.cspc.com.hk
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Executives
Ubs Group Ag 2201 Interest of corporation controlled by you
Cai Dong Chen 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Blackrock, Inc. 2201 Interest of corporation controlled by you
True Ally Holdings Limited 2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si 2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si 2101 Beneficial owner

CSPC Pharmaceutical Group Headlines

No Headlines